Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase
- PMID: 18174304
- PMCID: PMC2268374
- DOI: 10.1128/JCM.01886-07
Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase
Abstract
The cfr (chloramphenicol-florfenicol resistance) gene encodes a 23S rRNA methyltransferase that confers resistance to linezolid. Detection of linezolid resistance was evaluated in the first cfr-carrying human hospital isolate of linezolid and methicillin-resistant Staphylococcus aureus (designated MRSA CM-05) by dilution and diffusion methods (including Etest). The presence of cfr was investigated in isolates of staphylococci colonizing the patient's household contacts and clinical isolates recovered from patients in the same unit where MRSA CM-05 was isolated. Additionally, 68 chloramphenicol-resistant Colombian MRSA isolates recovered from hospitals between 2001 and 2004 were screened for the presence of the cfr gene. In addition to erm(B), the erm(A) gene was also detected in CM-05. The isolate belonged to sequence type 5 and carried staphylococcal chromosomal cassette mec type I. We were unable to detect the cfr gene in any of the human staphylococci screened (either clinical or colonizing isolates). Agar and broth dilution methods detected linezolid resistance in CM-05. However, the Etest and disk diffusion methods failed to detect resistance after 24 h of incubation. Oxazolidinone resistance mediated by the cfr gene is rare, and acquisition by a human isolate appears to be a recent event in Colombia. The detection of cfr-mediated linezolid resistance might be compromised by the use of the disk diffusion or Etest method.
Figures


Similar articles
-
Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.Clin Infect Dis. 2010 Mar 15;50(6):821-5. doi: 10.1086/650574. Clin Infect Dis. 2010. PMID: 20144045
-
Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid.Mol Microbiol. 2007 Jun;64(6):1506-14. doi: 10.1111/j.1365-2958.2007.05744.x. Mol Microbiol. 2007. PMID: 17555436 Free PMC article.
-
First Report of cfr-Carrying Plasmids in the Pandemic Sequence Type 22 Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type IV Clone.Antimicrob Agents Chemother. 2016 Apr 22;60(5):3007-15. doi: 10.1128/AAC.02949-15. Print 2016 May. Antimicrob Agents Chemother. 2016. PMID: 26953212 Free PMC article.
-
Tedizolid for the management of human infections: in vitro characteristics.Clin Infect Dis. 2014 Jan;58 Suppl 1:S35-42. doi: 10.1093/cid/cit616. Clin Infect Dis. 2014. PMID: 24343830 Review.
-
Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.Drug Resist Updat. 2014 Apr;17(1-2):1-12. doi: 10.1016/j.drup.2014.04.002. Epub 2014 Apr 6. Drug Resist Updat. 2014. PMID: 24880801 Review.
Cited by
-
In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.Braz J Microbiol. 2014 Oct 9;45(3):829-33. doi: 10.1590/s1517-83822014000300010. eCollection 2014. Braz J Microbiol. 2014. PMID: 25477914 Free PMC article.
-
Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.J Infect Dis. 2013 Jul;208(1):83-91. doi: 10.1093/infdis/jit138. Epub 2013 Apr 1. J Infect Dis. 2013. PMID: 23547139 Free PMC article.
-
In memoriam: John P. Quinn, MD.Clin Infect Dis. 2014 Mar;58(5):748-50. doi: 10.1093/cid/cit801. Epub 2013 Dec 12. Clin Infect Dis. 2014. PMID: 24336826 Free PMC article. No abstract available.
-
Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community.Am Health Drug Benefits. 2009 Feb;2(2):86-95. Am Health Drug Benefits. 2009. PMID: 25126276 Free PMC article.
-
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Clin Microbiol Rev. 2012 Jul;25(3):545-82. doi: 10.1128/CMR.05030-11. Clin Microbiol Rev. 2012. PMID: 22763637 Free PMC article. Review.
References
-
- Arias, C. A., J. Reyes, M. Zúñiga, L. Cortés, C. Cruz, C. L. Rico, D. Panesso, and the Columbian Antimicrobial Resistance Group (RESCOL). 2003. Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J. Antimicrob. Chemother. 5159-68. - PubMed
-
- Bonora, M. G., M. Ligozzi, A. Luzzani, M. Solbiati, E. Stepan, and R. Fontana. 2006. Emergence of linezolid resistance in Enterococcus faecium not dependent on linezolid treatment. Eur. J. Clin. Microbiol. Infect. Dis. 25197-198. - PubMed
-
- Bourgeois-Nicolaos, N., L. Massias, B. Couson, M. J. Butel, A. Andremont, and F. Doucet-Populaire. 2007. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J. Infect. Dis. 1951480-1488. - PubMed
-
- Chang, S., D. M. Sievert, J. C. Hageman, M. L. Boulton, F. C. Tenover, F. P. Downes, S. Shah, J. T. Rudrik, G. R. Pupp, W. J. Brown, D. Cardo, S. K. Fridkin, and the Vancomycin-Resistant Staphylococcus aureus Investigative Team. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 3481342-1347. - PubMed
-
- Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases